Our finding in zebrafish larvae that JNK inhibition decreased liver size and increased survival specifically in the context of activated β-catenin raises the possibility that β-catenin activation might confer sensitivity to JNK inhibition in other systems, including human liver cancer. This evidence concerns the gene MAPK8 and liver cancer.